Why the study?
Real-world data on diabetic medication use in Malaysian heart failure patients with T2DM had not been elucidated.
What is the prescribing pattern of antihyperglycemic agents in patients with heart failure and type 2 diabetes mellitus, and is glycemic control associated with LVEF?
What is the prescribing pattern of antihyperglycemic agents in patients with heart failure and type 2 diabetes mellitus, and is glycemic control associated with LVEF?
In a Malaysian cohort of patients with HF and T2DM, metformin was the most commonly prescribed antihyperglycemic agent, while SGLT-2 inhibitors were under-prescribed, highlighting a gap in evidence-based treatment.
No takes yet. Share an insight, caveat, or question.
Supports updating antihyperglycemic prescribing in Malaysian HF-T2DM; leaves open impact on LVEF and outcomes.
Lin et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: